» Articles » PMID: 38367157

Consensus Document on the Clinical Application of Invasive Functional Coronary Angiography from the Japanese Association of Cardiovascular Intervention and Therapeutics

Overview
Publisher Springer
Date 2024 Feb 17
PMID 38367157
Authors
Affiliations
Soon will be listed here.
Abstract

Invasive functional coronary angiography (FCA), an angiography-derived physiological index of the functional significance of coronary obstruction, is a novel physiological assessment tool for coronary obstruction that does not require the utilization of a pressure wire. This technology enables operators to rapidly evaluate the functional relevance of coronary stenoses during and even after angiography while reducing the burden of cost and complication risks related to the pressure wire. FCA can be used for treatment decision-making for revascularization, strategy planning for percutaneous coronary intervention, and procedure optimization. Currently, various software-computing FCAs are available worldwide, with unique features in their computation algorithms and functions. With the emerging application of this novel technology in various clinical scenarios, the Japanese Association of Cardiovascular Intervention and Therapeutics task force was created to outline expert consensus on the clinical use of FCA. This consensus document advocates optimal clinical applications of FCA according to currently available evidence while summarizing the concept, history, limitations, and future perspectives of FCA along with globally available software.

Citing Articles

Novel Applications of the Hybrid IVUS-OCT Imaging System: Suitable Lesions for Hybrid Imaging-Based Physiological Assessment.

Ishida M JACC Asia. 2025; 5(2):242-244.

PMID: 39967213 PMC: 11840266. DOI: 10.1016/j.jacasi.2024.11.022.


Contemporary Functional Coronary Angiography: An Update.

Bennett J, Chandrasekhar S, Woods E, McLean P, Newman N, Montelaro B Future Cardiol. 2024; 20(14):755-778.

PMID: 39445463 PMC: 11622791. DOI: 10.1080/14796678.2024.2416817.


Quantitative flow ratio versus fractional flow reserve for Heart Team decision-making in multivessel disease: the randomised, multicentre DECISION QFR trial.

Asano T, Tanigaki T, Hoshino M, Yasunaga M, Nonaka H, Emori H EuroIntervention. 2024; 20(9):561-570.

PMID: 38726719 PMC: 11067723. DOI: 10.4244/EIJ-D-23-00674.

References
1.
Westra J, Tu S, Campo G, Qiao S, Matsuo H, Qu X . Diagnostic performance of quantitative flow ratio in prospectively enrolled patients: An individual patient-data meta-analysis. Catheter Cardiovasc Interv. 2019; 94(5):693-701. DOI: 10.1002/ccd.28283. View

2.
Engstrom T, Kelbaek H, Helqvist S, Hofsten D, Klovgaard L, Holmvang L . Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015; 386(9994):665-71. DOI: 10.1016/s0140-6736(15)60648-1. View

3.
Dai N, Zhang R, Hu N, Guan C, Zou T, Qiao Z . Integrated coronary disease burden and patterns to discriminate vessels benefiting from percutaneous coronary intervention. Catheter Cardiovasc Interv. 2021; 99(1):E12-E21. DOI: 10.1002/ccd.29983. View

4.
Omori H, Witberg G, Kawase Y, Tanigaki T, Okamoto S, Hirata T . Angiogram based fractional flow reserve in patients with dual/triple vessel coronary artery disease. Int J Cardiol. 2019; 283:17-22. DOI: 10.1016/j.ijcard.2019.01.072. View

5.
Johnson N, Toth G, Lai D, Zhu H, Acar G, Agostoni P . Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol. 2014; 64(16):1641-54. DOI: 10.1016/j.jacc.2014.07.973. View